Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy

Patients with advanced‐stage follicular lymphoma (FL) who progress early after receiving first‐line therapy have poor overall survival (OS). Currently applied clinical prognostic models such as FL International Prognostic Index [FLIPI], FLIPI‐2 and PRIMA‐Prognostic Index [PRIMA‐PI] have suboptimal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Farheen, Mattiello, Federico, Grigg, Andrew, Herold, Michael, Hiddemann, Wolfgang, Marcus, Robert, Seymour, John F., Bolen, Christopher R., Knapp, Andrea, Nielsen, Tina, Casulo, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756469/
https://www.ncbi.nlm.nih.gov/pubmed/32815559
http://dx.doi.org/10.1002/ajh.25973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756469/
https://www.ncbi.nlm.nih.gov/pubmed/32815559
http://dx.doi.org/10.1002/ajh.25973

Ejemplares similares